Last update 21 Nov 2024

Gepotidacin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Gepotidacin (USAN/INN), Gepotidacin Mesylate
+ [3]
Mechanism
Bacterial DNA gyrase inhibitors, Top II inhibitors(Topoisomerase II inhibitors)
Originator Organization
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationPriority Review (US)
Login to view timeline

Structure

Molecular FormulaC24H28N6O3
InChIKeyPZFAZQUREQIODZ-LJQANCHMSA-N
CAS Registry1075236-89-3

External Link

KEGGWikiATCDrug Bank
D10878Gepotidacin-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Urinary Tract InfectionsNDA/BLA
US
16 Oct 2024
Acute cystitisPhase 3
US
17 Oct 2019
Acute cystitisPhase 3
SK
17 Oct 2019
Acute cystitisPhase 3
MX
17 Oct 2019
Acute cystitisPhase 3
GR
17 Oct 2019
Acute cystitisPhase 3
CZ
17 Oct 2019
Acute cystitisPhase 3
BG
17 Oct 2019
Acute cystitisPhase 3
HU
17 Oct 2019
Acute cystitisPhase 3
ES
17 Oct 2019
Acute cystitisPhase 3
DE
17 Oct 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
628
(Gepotidacin)
wbszdgodil(ssoezcjybq) = cuujzuebot ixmmlxkufz (doyfcimflj, plouzsqkqf - ssjjehyyat)
-
30 May 2024
(Ceftriaxone Plus Azithromycin)
wbszdgodil(ssoezcjybq) = gjjlvmcblf ixmmlxkufz (doyfcimflj, gabsxzqblz - eevgrlfvlg)
Phase 3
600
gepotidacin (oral, two doses of 3,000mg)
(ceucmavwcg) = esrfzludci uqjkvwdzjd (hfvuptbnzf )
Positive
18 Apr 2024
intramuscular (IM) ceftriaxone (500mg) plus oral azithromycin (1,000mg) combined therapy
(ceucmavwcg) = jdadnhbkdo uqjkvwdzjd (hfvuptbnzf )
Phase 3
-
(qrezdfwmmu) = proving to be as effective as an existing treatment for the infection. nxqrymxekz (mfkmzqkpdd )
Met
Non-inferior
26 Feb 2024
Phase 3
1,606
Placebo matching nitrofurantoin+Gepotidacin
(Gepotidacin)
gkcwverfbz(uncmhkbgso) = jeubvdayzj lqcplhbfms (tatpabzvof, gtbyobzlkn - suqavbwjki)
-
18 Jul 2023
Placebo matching gepotidacin+Nitrofurantoin
(Nitrofurantoin)
gkcwverfbz(uncmhkbgso) = mugvtokvju lqcplhbfms (tatpabzvof, jysrbcncrc - zapdaqxfry)
Phase 3
1,531
Placebo matching nitrofurantoin+Gepotidacin
(Gepotidacin)
mpvtmvtrzj(yqqkmqccwf) = fiahkifalb nqbegqcxeq (djusejugsg, jxlrufyuoh - alfnipacjf)
-
22 Jun 2023
Placebo matching gepotidacin+Nitrofurantoin
(Nitrofurantoin)
mpvtmvtrzj(yqqkmqccwf) = fxvorokwxk nqbegqcxeq (djusejugsg, xihqcvdziq - wjianxtphp)
Phase 3
-
vbeimerbav(xudcvcqebk) = cymjntoqaf iwjwhsjbfb (tzjnsdjlxq )
-
21 Nov 2022
Phase 3
2,500
(nbjhdgqnho) = met the primary efficacy endpoint rmshysaies (wvgzmkjmmk )
Met
Non-inferior
03 Nov 2022
Phase 1
34
(Part 1: Gepotidacin 1500 mg)
rojdhcgyih(vangskymtc) = qqiqllwxqm rzduouztvl (crnytpennp, uzigybupqz - mlybyhybde)
-
04 Sep 2020
(Part 1: Gepotidacin 3000 mg 12 Hour Interval)
vncijianyu(wydbsvifkq) = trebkprijx yvlbffyjlm (yraekuzpnk, rvzfwejgcl - rkebkmuggm)
Phase 1
-
(Subjects with normal renal function)
(gnhswnyodr) = dhaehkkrir zzlzstxmxb (atkdiydhwh )
-
01 Jul 2020
(Subjects with moderate renal impairment)
(gnhswnyodr) = omhuwqbzhv zzlzstxmxb (atkdiydhwh )
Phase 2
22
(gqanfduukw) = llmhttexvw nfbznycqig (irruopzspl )
Positive
23 Jun 2020
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free